iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/23756634
Effects of Schedule I drug laws on neuroscience research and treatment innovation - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;14(8):577-85.
doi: 10.1038/nrn3530. Epub 2013 Jun 12.

Effects of Schedule I drug laws on neuroscience research and treatment innovation

Affiliations

Effects of Schedule I drug laws on neuroscience research and treatment innovation

David J Nutt et al. Nat Rev Neurosci. 2013 Aug.

Abstract

Many psychoactive drugs are used recreationally, particularly by young people. This use and its perceived dangers have led to many different classes of drugs being banned under national laws and international conventions. Indeed, the possession of cannabis, 3,4-methylenedioxy-N-methylamphetamine (MDMA; also known as ecstasy) and psychedelics is stringently regulated. An important and unfortunate outcome of the controls placed on these and other psychoactive drugs is that they make research into their mechanisms of action and potential therapeutic uses - for example, in depression and post-traumatic stress disorder - difficult and in many cases almost impossible.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Ann Clin Psychiatry. 2007 Jan-Mar;19(1):45-52 - PubMed
    1. Expert Opin Pharmacother. 2009 Aug;10(11):1727-40 - PubMed
    1. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6 - PubMed
    1. J Psychoactive Drugs. 1998 Oct-Dec;30(4):371-9 - PubMed
    1. J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1125-32 - PubMed

LinkOut - more resources